Respiratory Medicine
Volume 103, Issue 8 , Pages 1091-1097 , August 2009

Exhaled breath condensate biomarkers in asbestos-related lung disorders

  • Sharron Chow

      Affiliations

    • Research and Education Unit, Workers' Compensation (Dust Diseases) Board of New South Wales, Sydney, Australia
    • Centre for Infection and Inflammation Research, School of Medical Sciences, University of New South Wales, Sydney, Australia
    • ,
  • Charlotte Campbell

      Affiliations

    • Department of Thoracic Medicine, St Vincent's Hospital, Sydney, Australia
    • ,
  • Alessandra Sandrini

      Affiliations

    • Research and Education Unit, Workers' Compensation (Dust Diseases) Board of New South Wales, Sydney, Australia
    • Department of Thoracic Medicine, St Vincent's Hospital, Sydney, Australia
    • ,
  • Paul S. Thomas

      Affiliations

    • Centre for Infection and Inflammation Research, School of Medical Sciences, University of New South Wales, Sydney, Australia
    • ,
  • Anthony R. Johnson

      Affiliations

    • Research and Education Unit, Workers' Compensation (Dust Diseases) Board of New South Wales, Sydney, Australia
    • ,
  • Deborah H. Yates

      Affiliations

    • Research and Education Unit, Workers' Compensation (Dust Diseases) Board of New South Wales, Sydney, Australia
    • Department of Thoracic Medicine, St Vincent's Hospital, Sydney, Australia
    • Corresponding Author InformationCorresponding author: Department of Thoracic Medicine, St Vincent's Hospital, Victoria Street, Darlinghurst, Sydney 2010, Australia. Tel.: +61 2 8382 2330; fax: +61 2 8382 2550.

Received 4 September 2008 ,Accepted 2 April 2009.

References 

  1. Berry G, Musk AW, De Klerk NH, et al. Predictions of mortality from mesothelioma. Occup Environ Med. 2003;60:458
  2. Clements M, Berry G, Shi J, et al. Projected mesothelioma incidence in men in New South Wales. Occup Environ Med. 2007;64:747–752
  3. Stayner LT, Kuempel E, Gilbert S, et al. An epidemiologic study of the role of chrysotile asbestos fiber dimensions in determining respiratory disease risk in exposed workers. Occup Environ Med. 2007;
  4. Beckett WS. Shipyard workers and asbestos: a persistent and international problem. Occup Environ Med. 2007;64:639–641
  5. Diagnosis and initial management of nonmalignant diseases related to asbestos. Am J Respir Crit Care Med. 2004;170:691–715
  6. Yates DH, Browne K, Stidolph PN, et al. Asbestos-related bilateral diffuse pleural thickening: natural history of radiographic and lung function abnormalities. Am J Respir Crit Care Med. 1996;153:301–306
  7. Kamp DW, Weitzman SA. The molecular basis of asbestos induced lung injury. Thorax. 1999;54:638–652
  8. Kharitonov SA, Yates D, Robbins RA, et al. Increased nitric oxide in exhaled air of asthmatic patients. Lancet. 1994;343:133–135
  9. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med. 2005;171:912–930
  10. Sandrini A, Johnson AR, Thomas PS, et al. Fractional exhaled nitric oxide concentration is increased in asbestosis and pleural plaques. Respirology. 2006;11:325–329
  11. Lehtonen H, Oksa P, Lehtimaki L, et al. Increased alveolar nitric oxide concentration and high levels of leukotriene B(4) and 8-isoprostane in exhaled breath condensate in patients with asbestosis. Thorax. 2007;62:602–607
  12. Paredi P, Kharitonov SA, Loukides S, et al. Exhaled nitric oxide is increased in active fibrosing alveolitis. Chest. 1999;115:1352–1356
  13. Horvath I, Hunt J, Barnes PJ, et al. Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J. 2005;26:523–548
  14. Jackson AS, Sandrini A, Campbell C, et al. Comparison of biomarkers in exhaled breath condensate and bronchoalveolar lavage. Am J Respir Crit Care Med. 2007;175:222–227
  15. Cepelak I, Dodig S. Exhaled breath condensate: a new method for lung disease diagnosis. Clin Chem Lab Med. 2007;45:945–952
  16. Vallyathan V, Mega JF, Shi X, et al. Enhanced generation of free radicals from phagocytes induced by mineral dusts. Am J Respir Cell Mol Biol. 1992;6:404–413
  17. Goodglick LA, Kane AB. Cytotoxicity of long and short crocidolite asbestos fibers in vitro and in vivo. Cancer Res. 1990;50:5153–5163
  18. Miller MR, Crapo R, Hankinson J, et al. Standardization of spirometry. Eur Respir J. 2005;26:319–338
  19. Cotes JE, Chinn DJ, Quanjer PH, et al. Standardization of the measurement of transfer factor (diffusing capacity). Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl. 1993;16:41–52
  20. Beckmann JS, Ye YZ, Anderson PG, et al. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol Chem Hoppe Seyler. 1994;375:81–88
  21. Montuschi P, Kharitonov SA, Ciabattoni G, et al. Exhaled 8-isoprostane as a new non-invasive biomarker of oxidative stress in cystic fibrosis. Thorax. 2000;55:205–209
  22. Vaughan J, Ngamtrakulpanit L, Pajewski TN, et al. Exhaled breath condensate pH is a robust and reproducible assay of airway acidity. Eur Respir J. 2003;22:889–894
  23. Piipari R, Piirila P, Keskinen H, et al. Exhaled nitric oxide in specific challenge tests to assess occupational asthma. Eur Respir J. 2002;20:1532–1537
  24. Pelclova D, Fenclova Z, Kacer P, et al. Arachidonic acid derivatives in the exhaled breath condensate in pneumoconioses and their correlation with individual factors. Chemicke Listy. 2007;101:s144–s146
  25. Pelclova D, Fenclova Z, Kacer P, et al. Exhaled breath condensate in asbestos exposure. Chest. 2005;128:345S–346S
  26. Peterson MW, Walter ME, Gross TJ. Asbestos directly increases lung epithelial permeability. Am J Physiol. 1993;265:L308–L317
  27. Kinnula VL. Oxidant and antioxidant mechanisms of lung disease caused by asbestos fibres. Eur Respir J. 1999;14:706–716
  28. Mossman BT, Churg A. Mechanisms in the pathogenesis of asbestosis and silicosis. Am J Respir Crit Care Med. 1998;157:1666–1680
  29. Liu JY, Brass DM, Hoyle GW, et al. TNF-alpha receptor knockout mice are protected from the fibroproliferative effects of inhaled asbestos fibers. Am J Pathol. 1998;153:1839–1847
  30. Liu JY, Morris GF, Lei WH, et al. Rapid activation of PDGF-A and -B expression at sites of lung injury in asbestos-exposed rats. Am J Respir Cell Mol Biol. 1997;17:129–140
  31. Kharitonov SA, Barnes PJ. Exhaled markers of inflammation. Curr Opin Allergy Clin Immunol. 2001;1:217–224
  32. Hunt JF, Fang K, Malik R, et al. Endogenous airway acidification. Implications for asthma pathophysiology. Am J Respir Crit Care Med. 2000;161:694–699
  33. Do R, Bartlett KH, Chu W, et al. Within- and between-person variability of exhaled breath condensate pH and NH4+ in never and current smokers. Respir Med. 2008;102:457–463
  34. Garey KW, Neuhauser MM, Robbins RA, et al. Markers of inflammation in exhaled breath condensate of young healthy smokers. Chest. 2004;125:22–26
  35. Kharitonov SA, Yates DH, Chung KF, et al. Changes in the dose of inhaled steroid affect exhaled nitric oxide levels in asthmatic patients. Eur Respir J. 1996;9:196–201
  36. Kharitonov SA, Barnes PJ. Effects of corticosteroids on noninvasive biomarkers of inflammation in asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2004;1:191–199
  37. Van Hoydonck PG, Wuyts WA, Vanaudenaerde BM, et al. Quantitative analysis of 8-isoprostane and hydrogen peroxide in exhaled breath condensate. Eur Respir J. 2004;23:189–192
  38. Rosias PP, Robroeks CM, Kester A, et al. Biomarker reproducibility in exhaled breath condensate collected with different condensers. Eur Respir J. 2008;31:934–942
  39. Liu J, Conrad DH, Chow S, et al. Collection devices influence the constituents of exhaled breath condensate. Eur Respir J. 2007;30:807–808
  40. Prieto L, Ferrer A, Palop J, et al. Differences in exhaled breath condensate pH measurements between samples obtained with two commercial devices. Respir Med. 2007;101:1715–1720
  41. Uasuf CG, Jatakanon A, James A, et al. Exhaled carbon monoxide in childhood asthma. J Pediatr. 1999;135:569–574
  42. Psathakis K, Mermigkis D, Papatheodorou G, et al. Exhaled markers of oxidative stress in idiopathic pulmonary fibrosis. Eur J Clin Invest. 2006;36:362–367
  43. Ojoo JC, Mulrennan SA, Kastelik JA, et al. Exhaled breath condensate pH and exhaled nitric oxide in allergic asthma and in cystic fibrosis. Thorax. 2005;60:22–26
  44. Effros R, Casaburi R, Su J, et al. The effects of volatile salivary acids and bases on exhaled breath condensate pH. Am J Respir Crit Care Med. 2006;173:386–392
  45. Hunt J. Airway acidification: interactions with nitrogen oxides and airway inflammation. Curr Allergy Asthma Rep. 2006;6:47–52

PII: S0954-6111(09)00106-1

doi: 10.1016/j.rmed.2009.04.009

Respiratory Medicine
Volume 103, Issue 8 , Pages 1091-1097 , August 2009

Article Tools

* Image Usage & Resolution